Lawrenz, M., Visekruna, A., Kuhl, A., Schmidt, N., Kaufmann, S. H. E., & Steinhoff, U. (2012). Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease. Mucosal Immunology, 5(2), 129-139. doi:10.1038/mi.2011.57.